跳至主要内容
临床试验/EUCTR2012-004605-27-IT
EUCTR2012-004605-27-IT进行中(未招募)不适用

Study Prospective Randomized Controlled Double-Blind: Comparison of tear substitute (Siccafluid) and Autologous Serum in Dry Eye Disease - Siccafluid and autologous serum

AZIENDA OSPEDALIERA ARCISPEDALE S. MARIA NUOVA0 个研究点开始时间: 2012年10月25日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1 - Presence of altered cornea (punctate keratopathy) and / or conjunctival least grade I ° according to the classification scheme of Oxford (Annex A) after staining with fluorescein to the cornea and conjunctiva with lissamine green for.
  • 2 - Tear break-up time fluorescein <10 sec (established cut-off for the diagnosis of dry eye by Lemp and Hamill in 1973)
  • 3 - Presence of dry eye caused by:
  • by reduction of tear production (Aqueous Deficient Dry Eye ADDE) and comprises:
  • dry eye associated with Sjogren's syndrome
  • Primary: presence of ADDE in combination with the symptoms of dry mouth, presence of autoantibodies, evidence of reduced salivary secretion and score positive on biopsy of a minor salivary gland.
  • Secondary: combines the features of primary SS with features of autoimmune connective tissue disease a clear (RA, systemic lupus erythematosus, polyarteritis nodosa, Wegener's granulomatosis, systemic sclerosis, primary biliary sclerosis)
  • dry eye not associated with Sjögren's syndrome:
  • for primary and secondary deficiencies of the lacrimal gland
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 64
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 85

排除标准

  • a. duct obstruction of the lacrimal gland
  • b. causes of increased tear evaporation causes intrinsic
  • c. Systemic use of drugs that could affect the tear film, tear secretion or the surface area of ??the eye (eg pilocarpine).
  • d. The use of previous or concurrent topical medications that may affect the evaluation of the drug's
  • and. History of previous ocular surgery, including refractive surgery, eyelid surgery or corneal surgery.
  • f. extrinsic causes (disorders of the ocular surfaces, use of contact lenses, allergic conjunctivitis)
  • g. Contraindications to the use of autologous serum: Hemoglobinopathies with high levels of bilirubin, viral and fungal infections bacterial active; Paraproteinemie; postivi Serology tests (HIV, HCV, HBV).
  • h. Age <18 years

研究者

发起方
AZIENDA OSPEDALIERA ARCISPEDALE S. MARIA NUOVA

相似试验